ClinicalTrials.gg
RecruitingNCT07889791Updated Oct 22, 2026

Effects Of Core Canister Training in Pregnant Women With History of Gestational Diabetes Mellitus

An interventional study of core canister training and traditional antenatal exercises in Antenatal Care Model and Gestatiaonl Diabetes Mellitus, sponsored by University of Lahore. Recruiting at 1 site in Pakistan. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by University of Lahore · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

This randomized control trial aims to determine the effects of structured Core Canister Training on muscular thickness, lumbopelvic stability and pelvic floor function in pregnant women diagnosed with GDM

Read the detailed description

Gestational Diabetes Mellitus (GDM) affects 7-14% of pregnancies worldwide and is associated not only with metabolic dysregulation but also impaired neuromuscular coordination and pelvic floor dysfunction. The core canister, consisting of the diaphragm, transversus abdominis, lumbar multifidus, and pelvic floor muscles, plays a vital role in lumbopelvic stability and continence. Dysfunction of this system may contribute to low back pain, pelvic girdle pain, and urinary incontinence during pregnancy. This randomized control trial aims to determine the effects of structured Core Canister Training on muscular thickness, lumbopelvic stability and pelvic floor function in pregnant women diagnosed with GDM. It will be conducted in central park trust \& teaching hospital \& Riphah medical center Lahore.90 eligible Participants will be randomized to supervised core canister exercises and standard antenatal exercises, 45 participants in each group three times per week from 20-24 weeks of gestation up to 12 weeks exercise protocol. Primary outcomes include muscular thickness, lumbopelvic stability and pelvic floor muscle performance while secondary outcomes include metabolic outcomes. The tools will be Musculoskeletal Ultrasound Imaging, modified oxford classification, Active Straight Leg Raise Test, Y-Balance test, ICIQ-UI SF,KHQ,6 MWT,GAD-7, pad test. The Data will be analyzed using SPSS version 26.0.

02

Conditions studied

  • Antenatal Care Model
  • Gestatiaonl Diabetes Mellitus

Browse trials for

Keywords

  • aerobic exercise
  • pregnant women
  • gestational diabetes mellitus
  • rehabilitation exercises
  • pelvic floor
  • resistance training
03

In context

Diabetes, Gestational

857 studies on the registry are indexed under Diabetes, Gestational; 199 are open to participants now.

This study's planned enrollment of 90 is below the median of 110 across 560 interventional studies indexed under Diabetes, Gestational.

Browse Diabetes, Gestational studies →

Lead sponsor

University of Lahore is the lead sponsor of 230 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently in their second pregnancy
  • Documented history of GDM in the first pregnancy
  • Gestational age 20-24 weeks at the time of enrollment. The upper limit of gestational age will set at 24 weeks at the time of inclusion to allow for at least 12 weeks of intervention.
  • Singleton pregnancy
  • Body mass index (BMI) \<40 kg/m2)
  • Muscle strength of upper \& lower limb at level IV or above
  • Suffering from stress urinary incontinence diagnosed by Cough Stress Test.
  • Medically cleared for physical activity by their obstetrician

Exclusion criteria

Exclusion Criteria:

  • Pre-existing type 1 or type 2 diabetes mellitus
  • Previous history of abortion
  • Patients with severe obstetric complications and contraindications listed in the 2023 of BMJ entitled Public health guidelines for physical activity during pregnancy
  • High-risk obstetric complications (e.g., preeclampsia, placenta previa)
  • Musculoskeletal or neurological disorders limiting physical activity
  • Any current or previous pelvic floor dysfunction diagnosed by healthcare professionals like pelvic organ prolapse grade III or IV
  • Participation in any other structured exercise or lifestyle intervention program
  • Severe damage to the heart, liver, lungs, or kidneys
  • Acute or chronic complications caused by diabetes, such as ketoacidosis or diabetic foot
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Core Canister Training

    Core Canister Training targets diaphragm, transversus abdominus, multifidus, pelvic floor exercises

    Other: core canister training

  • Active comparator
    traditional antenatal exercises

    The activation of TrA muscle was performed in different positions and progressed from static to dynamic conditions along with baseline treatment(aerobic and resistive ex)

    Other: traditional antenatal exercises

Interventions

  • Othercore canister training

    •Baseline Treatment: (aerobic + resistive ex) 10min resistive,10 min relaxation ex Diaphragmatic breathing ex:5min rest-5min ex-5min rest/daily • Core \& TrA, pelvic floor\& multifidus: 10 sets of 10 seconds each, 3 sessions per week for 40min Total 12 weeks

  • Othertraditional antenatal exercises

    •Baseline Treatment: (aerobic + resistive ex) 10min resistive,10 min relaxation ex transversus abdominus focused exercises: 3 sessions per week ,25min per session Total 12 weeks

06

What researchers measure

Primary outcomes

  1. Musculoskeletal Ultrasound Imaging

    is a non-invasive, real-time imaging technique used to quantify muscle thickness and activation widely used in clinical and research settings. Studies consistently show excellent within-examiner reliability (ICC ≥ 0.90) for core muscle thickness measurements across different muscles

    Time frame: 12th week

  2. Modified oxford scale

    A 6-point digital vaginal palpation scale (0-5) used to grade voluntary pelvic floor muscle strength in women. Correlation coefficients reported between r = 0.60-0.80, Indicates moderate to strong correlation with instrumented measures and intra-rater Reliability is generally good to excellent (ICC range: \~0.80-0.95).

    Time frame: 12th week

  3. Active Straight Leg Raise (ASLR) Test

    The Active Straight Leg Raise (ASLR) Test is a functional clinical test used to assess ability to generate and transfer load/motor control across the lumbopelvic region, particularly in patients with pelvic girdle pain and suspected instability. Test-Retest Reliability is good to excellent (ICC ≈ 0.83 and Pearson's r ≈ 0.87)

    Time frame: 12th week

  4. Y-Balance Test (YBT)

    The Y-Balance Test (YBT) is a clinical dynamic balance and functional stability test derived from the Star Excursion Balance Test that assesses a person's ability to maintain balance and control while reaching in three directions (anterior, posteromedial, posterolateral) on a single stance leg - reflecting aspects of lumbopelvic motor control and dynamic stability. Excellent inter-rater reliability has been reported: ICC ≈ 0.99-1.00 for reach distances and composite scores in young adults with chronic low back pain

    Time frame: 12th week

  5. International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF)

    A short, self-reported questionnaire (3 scored items + 1 unscored) that assesses frequency, severity, and impact of urinary incontinence on quality of life. Widely used in clinical and research settings, including pregnancy and postpartum women. Reliability: Excellent test-retest reliability with ICC = 0.95. Validity: Strong construct validity, correlating well with bladder diaries and pad tests (r = 0.72-0.89). Good internal consistency: Cronbach's α = 0.91

    Time frame: 12th week

  6. King's Health Questionnaire (KHQ)

    A condition-specific, self-administered quality-of-life questionnaire for urinary incontinence (UI). It consists of 21 items in 9 domains (e.g., general health, incontinence impact, role/emotional/physical/social limitations, sleep/energy, severity measures, and personal relationships). Reliability: High internal consistency: Cronbach's α = 0.72-0.97 across domains. Excellent test-retest reliability: ICC = 0.79-0.93. Validity: (correlation coefficients r = 0.60-0.80).

    Time frame: 12th week

07

Study locations

1 of 1 sites recruiting
  • Central Park trust & teaching hospital, Riphah medical center
    Lahore, Punjab Province 6400, Pakistan
    • Maryam Professor, HoD, University Institute of Physical Therapy, PhD · Contact · maryam.shabbir@uipt.uol.edu.pk · 03004391550
    • Hina gul, PhD* · Principal investigator
    Recruiting
08

References and documents

Publications

  • Prudencio CB, Nunes SK, Pinheiro FA, Sartorao Filho CI, Nava GTA, Salomoni SE, Pedroni CR, Rudge MVC, Barbosa AMP; Diamater Study Group. Gestational diabetes is associated with alteration on pelvic floor muscle activation pattern during pregnancy and postpartum: Prospective cohort using electromyography assessment. Front Endocrinol (Lausanne). 2022 Oct 6;13:958909. doi: 10.3389/fendo.2022.958909. eCollection 2022. PubMed 36277705 ↗
  • Phelan S, Jelalian E, Coustan D, Caughey AB, Castorino K, Hagobian T, Munoz-Christian K, Schaffner A, Shields L, Heaney C, McHugh A, Wing RR. Randomized controlled trial of prepregnancy lifestyle intervention to reduce recurrence of gestational diabetes mellitus. Am J Obstet Gynecol. 2023 Aug;229(2):158.e1-158.e14. doi: 10.1016/j.ajog.2023.01.037. Epub 2023 Feb 8. PubMed 36758710 ↗
  • Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational Diabetes Mellitus-Recent Literature Review. J Clin Med. 2022 Sep 28;11(19):5736. doi: 10.3390/jcm11195736. PubMed 36233604 ↗
  • Lu Y, Huang J, Yan J, Wei Q, He M, Yuan C, Long Y. Meta-analysis of risk factors for recurrent gestational diabetes mellitus. BMC Pregnancy Childbirth. 2025 Mar 8;25(1):257. doi: 10.1186/s12884-025-07367-9. PubMed 40057727 ↗
  • Huifen Z, Yaping X, Meijing Z, Huibin H, Chunhong L, Fengfeng H, Yaping Z. Effects of moderate-intensity resistance exercise on blood glucose and pregnancy outcome in patients with gestational diabetes mellitus: A randomized controlled trial. J Diabetes Complications. 2022 May;36(5):108186. doi: 10.1016/j.jdiacomp.2022.108186. Epub 2022 Mar 29. PubMed 35379538 ↗
  • Dipla K, Zafeiridis A, Mintziori G, Boutou AK, Goulis DG, Hackney AC. Exercise as a Therapeutic Intervention in Gestational Diabetes Mellitus. Endocrines. 2021 Jun;2(2):65-78. doi: 10.3390/endocrines2020007. Epub 2021 Mar 26. PubMed 33870263 ↗
  • Arslan M, Kozan R. Pelvic floor dysfunction in patients with gestational diabetes mellitus. World J Diabetes. 2025 Feb 15;16(2):99823. doi: 10.4239/wjd.v16.i2.99823. PubMed 39959261 ↗
  • Adnan M, Aasim M. Prevalence of gestational diabetes mellitus in Pakistan: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Feb 3;24(1):108. doi: 10.1186/s12884-024-06290-9. PubMed 38310244 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889791
Responsible party
Sponsor
First posted
Oct 22, 2026
Start date
Jul 20, 2026
Primary completion
May 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Maryam Shabbir, PhD
principal investigator · University of Lahore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion